• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Erythropoiesis-stimulating agents in sickle cell anaemia.镰状细胞贫血中的促红细胞生成素
Br J Haematol. 2018 Aug;182(4):602-605. doi: 10.1111/bjh.14846. Epub 2017 Jul 27.
2
Dose efficiency of erythropoiesis-stimulating agents for the treatment of patients with chemotherapy-induced anemia: a systematic review.促红细胞生成素刺激剂治疗化疗所致贫血患者的剂量效率：一项系统评价
Clin Ther. 2014 Apr 1;36(4):594-610. doi: 10.1016/j.clinthera.2014.02.007. Epub 2014 Mar 18.
3
Comparison of pain and efficacy of darbepoetin alfa and epoetin Beta pegol treatment in patients receiving peritoneal dialysis.接受腹膜透析患者中，达贝泊汀α与聚乙二醇化促红细胞生成素β治疗的疼痛及疗效比较。
J Nippon Med Sch. 2015;82(1):21-6. doi: 10.1272/jnms.82.21.
4
Evaluation of the effect of voxelotor and darbepoetin alfa on hemoglobin levels in patients with sickle cell disease.评估罗沙司他和达贝泊汀对镰状细胞病患者血红蛋白水平的影响。
Expert Rev Hematol. 2024 Jun;17(6):255-260. doi: 10.1080/17474086.2024.2352497. Epub 2024 May 16.
5
Darbepoetin Administration in Term and Preterm Neonates.促红细胞生成素在足月儿和早产儿中的应用。
Clin Perinatol. 2015 Sep;42(3):557-66. doi: 10.1016/j.clp.2015.04.016. Epub 2015 May 23.
6
Darbepoetin alfa for anemia with myelodysplastic syndrome.聚乙二醇化促红细胞生成素α用于治疗骨髓增生异常综合征所致贫血
Expert Rev Hematol. 2015 Apr;8(2):139-46. doi: 10.1586/17474086.2015.1000854. Epub 2015 Jan 12.
7
Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin.用达贝泊汀和促红细胞生成素治疗的早产儿的学前评估
Pediatrics. 2016 Mar;137(3):e20153859. doi: 10.1542/peds.2015-3859. Epub 2016 Feb 15.
8
Guidelines for using darbepoetin alfa in patients with chemotherapy-induced anemia.
Pharmacotherapy. 2003 Dec;23(12 Pt 2):110S-118S. doi: 10.1592/phco.23.16.110s.31970.
9
Change in darbepoetin alfa administration schedule affects erythropoiesis-stimulating agent resistance in patients with chronic kidney disease receiving hemodialysis.达比加群酯给药方案的改变会影响接受血液透析的慢性肾病患者对促红细胞生成素的抵抗。
Ren Fail. 2008;30(8):778-83. doi: 10.1080/08860220802248977.
10
An overview of the pharmacokinetic disposition of darbepoetin alfa.
Pharmacotherapy. 2002 Sep;22(9 Pt 2):133S-140S. doi: 10.1592/phco.22.14.133s.33396.

引用本文的文献

1
Inhibition of sodium-glucose cotransporter-2 improves anaemia in mice and humans with sickle cell disease, and reduces infarct size in a murine stroke model.钠-葡萄糖共转运蛋白 2 抑制剂可改善镰状细胞病小鼠和人类的贫血，并减少小鼠卒中模型中的梗死面积。
J Cell Mol Med. 2024 Sep;28(17):e70091. doi: 10.1111/jcmm.70091.
2
Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease.溶血驱动的 IFNα 产生通过负向调节镰状细胞病中的 EPO 信号转导来损害红细胞生成。
Blood. 2024 Mar 14;143(11):1018-1031. doi: 10.1182/blood.2023021658.
3
Sickle Cell Disease and CKD: An Update.镰状细胞病与慢性肾脏病：最新进展。
Am J Nephrol. 2024;55(1):56-71. doi: 10.1159/000534865. Epub 2023 Oct 27.
4
Revisiting anemia in sickle cell disease and finding the balance with therapeutic approaches.重新审视镰状细胞病中的贫血症，并找到治疗方法的平衡点。
Blood. 2022 May 19;139(20):3030-3039. doi: 10.1182/blood.2021013873.
5
The nephropathy of sickle cell trait and sickle cell disease.镰状细胞性状和镰状细胞病的肾病
Nat Rev Nephrol. 2022 Jun;18(6):361-377. doi: 10.1038/s41581-022-00540-9. Epub 2022 Feb 21.
6
Administrative data identify sickle cell disease: A critical review of approaches in U.S. health services research.利用行政数据识别镰状细胞病：美国卫生服务研究中方法的批判性回顾。
Pediatr Blood Cancer. 2020 Dec;67(12):e28703. doi: 10.1002/pbc.28703. Epub 2020 Sep 17.
7
The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research.红细胞祖细胞中的促红细胞生成素-成纤维细胞生长因子23信号通路：开启一个新的研究领域。
Front Physiol. 2019 Mar 26;10:304. doi: 10.3389/fphys.2019.00304. eCollection 2019.

本文引用的文献

1
Identification and Validation of a Sickle Cell Disease Cohort Within Electronic Health Records.电子健康记录中镰状细胞病队列的识别与验证
Acad Pediatr. 2017 Apr;17(3):283-287. doi: 10.1016/j.acap.2016.12.005. Epub 2016 Dec 13.
2
Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.镰状细胞病中促红细胞生成素 - 羟基脲联合疗法：美国国立卫生研究院的经验及文献综述
Haematologica. 2006 Aug;91(8):1076-83.
3
F reticulocyte response in sickle cell anemia treated with recombinant human erythropoietin: a double-blind study.
Blood. 1993 Jan 1;81(1):9-14.
4
On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.关于羟基脲/促红细胞生成素联合疗法治疗镰状细胞病的应用
Acta Haematol. 1995;94(3):128-34. doi: 10.1159/000203994.
5
Erythropoietin and renal function in sickle-cell disease.镰状细胞病中的促红细胞生成素与肾功能
Br Med J (Clin Res Ed). 1982 Dec 11;285(6356):1686-8. doi: 10.1136/bmj.285.6356.1686.
6
Sickle cell anemia patients have low erythropoietin levels for their degree of anemia.镰状细胞贫血患者的促红细胞生成素水平与其贫血程度相比偏低。
Blood. 1986 Jan;67(1):46-9.
7
Erythropoietin in anemia of renal failure in sickle cell disease.促红细胞生成素在镰状细胞病肾衰竭贫血中的应用
N Engl J Med. 1991 Oct 17;325(16):1175-6. doi: 10.1056/NEJM199110173251614.
8
Erythropoietin for anemia of renal failure in sickle cell disease.促红细胞生成素用于镰状细胞病肾衰竭贫血
N Engl J Med. 1991 May 9;324(19):1369-70. doi: 10.1056/NEJM199105093241916.
9
Treatment of sickle cell anemia with hydroxyurea and erythropoietin.用羟基脲和促红细胞生成素治疗镰状细胞贫血。
N Engl J Med. 1990 Aug 9;323(6):366-72. doi: 10.1056/NEJM199008093230602.
10
Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure.重组人促红细胞生成素对纯合子镰状细胞贫血和肾衰竭患者红细胞生成的影响。
Nephrol Dial Transplant. 1992;7(8):817-21.

Erythropoiesis-stimulating agents in sickle cell anaemia.

作者信息

Han Jin, Zhou Jifang, Kondragunta Vinod, Zhang Xu, Molokie Robert E, Gowhari Michel, Hassan Johara, Jain Shivi, Calip Gregory S, Gordeuk Victor R, Saraf Santosh L

机构信息

Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, Chicago, IL, USA.

Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA.

出版信息

Br J Haematol. 2018 Aug;182(4):602-605. doi: 10.1111/bjh.14846. Epub 2017 Jul 27.

DOI:10.1111/bjh.14846
PMID:28748552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5787037/
Abstract
摘要